已收盘 12-19 16:00:00 美东时间
+0.356
+0.47%
Needham analyst Ryan Macdonald initiated coverage on Hims & Hers Health Inc. (NYSE:HIMS) at a Buy rating with a price target of $24. The analyst writes that, despite increased stock volatility with its entry into the compounded GLP-1 market, he anticipates a positive impact on HIMS’s fundamentals an...
2024-08-23 02:26